Long-term prognostic importance of transient left ventricular dilation during pharmacologic stress echocardiography

J Am Soc Echocardiogr. 2005 Jan;18(1):57-62. doi: 10.1016/j.echo.2004.08.035.

Abstract

Objectives: We sought to evaluate the prognostic significance of left ventricular (LV) transient ischemic dilation (TID) for patients with a positive stress echocardiogram (SE).

Background: TID during SE has been related to the presence of extensive coronary artery disease, but its long-term prognostic implications have not been reported.

Methods: In all, 99 consecutive patients with a positive SE comprised the study group. LV volumes were evaluated according to the modified Simpson's rule. TID during SE was defined as the presence of an increase in LV end-diastolic volume during the stress test. A clinical history was fulfilled for each patient and all of them were followed up.

Results: Of 99 patients, 32 (32.3%) showed TID. Mean age was 65.8 +/- 9.8 years for non-TID group and 70.2 +/- 8.4 for TID group (P = .048). Baseline characteristics and subsequent treatment were similar in both groups. Mean follow-up was 21.4 +/- 15.8 months. In non-TID group the mean survival free of acute myocardial infarction was 47.28 months and 39.7 months in TID group (log rank = 0.012). In the univariate and multivariate analysis only TID and the wall motion score index were found as independent predictors related to long-term prognosis (risk ratio = 6.9; 95% confidence interval = 0.8-59.6; P = .042; and risk ratio = 0.4; 95% confidence interval = 0.18-0.89; P = .047, respectively).

Conclusions: LV TID during SE is an easy and independent prognostic marker. It helps to select patients with increased risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Dilatation, Pathologic
  • Dipyridamole
  • Echocardiography, Stress*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Ischemia / diagnostic imaging
  • Myocardial Ischemia / pathology*
  • Myocardial Ischemia / physiopathology
  • Prognosis
  • Survival Analysis
  • Vasodilator Agents
  • Ventricular Dysfunction, Left / mortality*
  • Ventricular Dysfunction, Left / pathology
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Vasodilator Agents
  • Dipyridamole